Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
40,53 € ↓ -2,45 (-5,70%)
2026-06-05
DEL PRIS
SecurityDE:12V / Veracyte, Inc.
InstitutionHsbc Holdings Plc
Latest Disclosed Ownership13,186 shares
Latest Disclosed Value $ 423,798
Hsbc Holdings Plc reports 5.29% decrease in ownership of 12V / Veracyte, Inc.

On April 30, 2026 - Hsbc Holdings Plc filed a 13F-HR form disclosing ownership of 13,186 shares of Veracyte, Inc. (DE:12V) valued at $350,748 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 20, 2026 disclosing 13,922 shares of Veracyte, Inc.. This represents a change in shares of -5.29% during the quarter. The current value of the position is $534,429 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F VERACYTE COM 92337F107 13,186 -736 -5.29 424 -28.55 0.0000
2026-03-20 2025-12-31 13F/A-1 VERACYTE COM 92337F107 13,922 14 0.10 592 24.63 0.0003
2026-03-06 2025-12-31 13F VERACYTE COM 92337F107 13,922 14 592 0.0000
2025-11-13 2025-09-30 13F VERACYTE COM 92337F107 13,908 -10,471 -42.95 476 -28.03 0.0003
2025-08-13 2025-06-30 13F VERACYTE COM 92337F107 24,379 2,677 12.34 660 4.10 0.0004
2025-05-14 2025-03-31 13F VERACYTE COM 92337F107 21,702 10,618 95.80 635 43.12 0.0004
2025-02-14 2024-12-31 13F VERACYTE COM 92337F107 11,084 1,406 14.53 444 34.65 0.0003
2024-11-14 2024-09-30 13F VERACYTE COM 92337F107 9,678 -3,015 -23.75 329 21.40 0.0002
2024-08-12 2024-06-30 13F VERACYTE COM 92337F107 12,693 -297 -2.29 271 -5.57 0.0002
2024-05-15 2024-03-31 13F VERACYTE COM 92337F107 12,990 12,990 288 0.0002
2021-05-14 2021-03-31 13F VERACYTE COM 92337F107 0 -5,273 -100.00 0 -100.00
2021-02-25 2020-12-31 13F/A-1 VERACYTE COM 92337F107 5,273 -5,967 -53.09 261 -29.46 0.0003
2021-02-12 2020-12-31 13F VERACYTE COM 92337F107 5,273 -5,967 261 61.9710
2020-11-12 2020-09-30 13F VERACYTE COM 92337F107 11,240 1,918 20.57 370 53.53 0.0006
2020-08-14 2020-06-30 13F VERACYTE COM 92337F107 9,322 9,322 241 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.